Preliminary clinical and biologic results of GB1275, a first-in-class oral CD11b modulator, alone and with pembrolizumab, in advanced solid tumors (KEYNOTE A36) Meeting Abstract
| Authors: | Park, H.; Bendell, J. C.; Messersmith, W. A.; Rasco, D. W.; De Bono, J. S.; Strickler, J. H.; Zhou, L.; Carter, L. L.; Bruey, J. M.; Li, J.; Raghupathi, K.; Dupont, J.; Chaney, M. F.; Park, W. |
| Abstract Title: | Preliminary clinical and biologic results of GB1275, a first-in-class oral CD11b modulator, alone and with pembrolizumab, in advanced solid tumors (KEYNOTE A36) |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120601027 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.2505 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2505 -- Source: Wos |
